{
  "url": "https://openlegislation.uk/misuse-of-drugs-regulations-2001/regulation-18",
  "json_url": "https://openlegislation.uk/misuse-of-drugs-regulations-2001/regulation-18.json",
  "legislation": "uksi/2001/3998",
  "legislation_title": "The Misuse of Drugs Regulations 2001",
  "legislation_url": "https://openlegislation.uk/misuse-of-drugs-regulations-2001",
  "path": "regulation/18",
  "kind": "regulation",
  "number": "18",
  "heading": "Marking of bottles and other containers",
  "text": "(1) Subject to paragraph (2), no person shall supply a controlled drug otherwise than in a bottle, package or other container which is plainly marked—\n(a) in the case of a controlled drug other than a preparation, with the amount of the drug contained therein;\n(b) in the case of a controlled drug which is a preparation—\n(i) made up into tablets, capsules or other dosage units, with the amount of each component (being a controlled drug) of the preparation in each dosage unit and the number of dosage units in the bottle, package or other container;\n(ii) not made up as aforesaid, with the total amount of the preparation in the bottle, package or other container and the percentage of each of its components which is a controlled drug.\n(2) Nothing in this regulation shall have effect in relation to—\n(a) the drugs specified in Schedules 4 and 5 or poppy-straw;\n(b) any drug specified in Schedule 3 contained in or comprising a preparation which—\n(i) is required for use as a buffering agent in chemical analysis;\n(ii) has present in it both a substance specified in paragraph 1 or 2 of that Schedule and a salt of that substance; and\n(iii) is premixed in a kit;\n(c) any exempt product;\n(d) the supply of a controlled drug by or on the prescription of a practitioner, a supplementary prescriber, a nurse independent prescriber , registered chiropodist or registered podiatrist, paramedic independent prescriber, therapeutic radiographer independent prescriber or a pharmacist independent prescriber;\n(e) the supply of a controlled drug for administration in a clinical trial or a medicinal test on animals.\n(3) In this regulation—\n...\n“medicinal test on animals” has the same meaning as in the Medicines Act 1968.",
  "extent": "E+W+S+N.I.",
  "status": null,
  "version": "current",
  "annotations": [
    {
      "type": "F",
      "label": "F1",
      "text": "Reg. 18(2)(d) substituted (23.4.2012) by The Misuse of Drugs (Amendment No.2) (England, Wales and Scotland) Regulations 2012 (S.I. 2012/973), regs. 1(1), 13"
    },
    {
      "type": "F",
      "label": "F2",
      "text": "Words in reg. 18(2)(d) inserted (31.12.2023) by The Misuse of Drugs (England and Wales and Scotland) (Amendment) (No. 2) Regulations 2023 (S.I. 2023/1345), regs. 1(2), 10"
    },
    {
      "type": "F",
      "label": "F3",
      "text": "Reg. 18(3) substituted (1.5.2004) by The Medicines for Human Use (Clinical Trials) Regulations 2004 (S.I. 2004/1031), reg. 1, Sch. 10 Pt. 2 para. 16"
    },
    {
      "type": "F",
      "label": "F4",
      "text": "Words in reg. 18(3) omitted (1.11.2018) by virtue of The Misuse of Drugs (Amendments) (Cannabis and Licence Fees) (England, Wales and Scotland) Regulations 2018 (S.I. 2018/1055), regs. 1(1), 5"
    }
  ],
  "outstanding_effects": [],
  "provenance": {
    "source": "legislation.gov.uk",
    "source_url": "https://www.legislation.gov.uk/uksi/2001/3998/regulation/18",
    "retrieved_at": "2026-10-29T07:18:47.393467+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives."
}